skip to primary navigationskip to content

Madeline McNamara

Madeline McNamara

BHF Centre of Regenerative Medicine PhD Student

Research Interests

Supervisor: Dr Sanjay Sinha

Co-supervisor: Prof Shoumo Bhattacharya

Title: Development of new therapies for Marfan's syndrome using an in vitro human iPSC disease model

Abstract: Marfan’s syndrome (MFS) is a connective tissue disorder with pleiotropic manifestations including severe cardiovascular complications, such as aortic aneurysms and aortic rupture. Abnormal widening of aortic structures is caused by mutations in the extracellular matrix structural component, fibrillin-1. As a result, MFS patients display impairment in fibrillin-1 deposition, increased extracellular matrix degradation and excessive signalling by the transforming growth factor beta (TGF-β) pathway.

In this project, we will be using our human induced pluripotent stem cell (hiPSC)-derived in vitro model system for MFS to develop new therapies aimed at ameliorating the disease phenotype. Our approaches include correcting the mutations in FBN1, the gene coding for fibrillin-1, identifying targets downstream of dysfunctional FBN1 implicated in MFS pathogenesis, and transitioning our novel therapies into more physiologically relevant in vitro culture and in vivo model systems.


iPSC ; regenerative medicine


  • Marfan syndrome

Key Publications

An iPSC-derived vascular model of Marfan syndrome identifies key mediators of smooth muscle cell death. Granata A, Serrano F, Bernard WG, McNamara M, Low L, Sastry P, Sinha S. Nat Genet. 2017 Jan;49(1):97-109.


Cambridge Cardiovascular logo - transparent

Logo design by Dr Ana-Mishel Spiroski and Dr Sarah Morgan.


We connect cardiovascular researchers in Cambridge.

Please follow us on Twitter for local news about research, events, funding calls, and open positions.

For inquiries about our research or the website, please contact Dr Tammy Dougan